{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:47:50Z","timestamp":1792003670264,"version":"4.4.0"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s40266-024-01169-y","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T13:31:46Z","timestamp":1736256706000},"page":"39-55","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Influenza and Aging: Clinical Manifestations, Complications, and Treatment Approaches in Older Adults"],"prefix":"10.1007","volume":"42","author":[{"given":"Christian I.","family":"Rosero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Gravenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2514-3820","authenticated-orcid":false,"given":"Elie A.","family":"Saade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"1169_CR1","volume-title":"Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases","year":"2020","unstructured":"Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases. 9th ed. Philadelphia: Elsevier; 2020.","edition":"9"},{"issue":"10353","key":"1169_CR2","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0140-6736(22)00982-5","volume":"400","author":"TM Uyeki","year":"2022","unstructured":"Uyeki TM, Hui DS, Zambon M, Wentworth DE, Monto AS. Influenza. Lancet. 2022;400(10353):693\u2013706. https:\/\/doi.org\/10.1016\/S0140-6736(22)00982-5.","journal-title":"Lancet"},{"issue":"4","key":"1169_CR3","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3390\/v11040346","volume":"11","author":"I Kosik","year":"2019","unstructured":"Kosik I, Yewdell JW. Influenza hemagglutinin and neuraminidase: yin\u2212yang proteins coevolving to thwart immunity. Viruses. 2019;11(4):346. https:\/\/doi.org\/10.3390\/v11040346.","journal-title":"Viruses"},{"key":"1169_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(24)00066-1","author":"S Caini","year":"2024","unstructured":"Caini S, et al. Probable extinction of influenza B\/Yamagata and its public health implications: a systematic literature review and assessment of global surveillance databases. Lancet Microbe. 2024. https:\/\/doi.org\/10.1016\/S2666-5247(24)00066-1.","journal-title":"Lancet Microbe"},{"issue":"1","key":"1169_CR5","doi-asserted-by":"publisher","first-page":"ofac664","DOI":"10.1093\/ofid\/ofac664","volume":"10","author":"P Kim","year":"2023","unstructured":"Kim P, et al. Burden of severe illness associated with laboratory-confirmed influenza in adults aged 50\u201364 years, 2010\u20132011 to 2016\u20132017. Open Forum Infect Dis. 2023;10(1):ofac664. https:\/\/doi.org\/10.1093\/ofid\/ofac664.","journal-title":"Open Forum Infect Dis"},{"issue":"10095","key":"1169_CR6","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0140-6736(17)30129-0","volume":"390","author":"C Paules","year":"2017","unstructured":"Paules C, Subbarao K. Influenza. Lancet Lond Engl. 2017;390(10095):697\u2013708. https:\/\/doi.org\/10.1016\/S0140-6736(17)30129-0.","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"1169_CR7","first-page":"2","volume":"42","author":"M Moghadami","year":"2017","unstructured":"Moghadami M. A narrative review of influenza: a seasonal and pandemic disease. Iran J Med Sci. Jan.2017;42(1):2\u201313.","journal-title":"Iran. J. Med. Sci."},{"issue":"1","key":"1169_CR8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3904\/kjim.2014.29.1.132","volume":"29","author":"WS Choi","year":"2014","unstructured":"Choi WS, et al. Severe influenza treatment guideline. Korean J Intern Med. 2014;29(1):132. https:\/\/doi.org\/10.3904\/kjim.2014.29.1.132.","journal-title":"Korean J Intern Med"},{"issue":"2","key":"1169_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/infdis\/jix571","volume":"217","author":"S-S Wong","year":"2018","unstructured":"Wong S-S, et al. Severe influenza is characterized by prolonged immune activation: results from the SHIVERS cohort study. J Infect Dis. 2018;217(2):245\u201356. https:\/\/doi.org\/10.1093\/infdis\/jix571.","journal-title":"J Infect Dis"},{"issue":"1","key":"1169_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169679","volume":"12","author":"D Lu","year":"2017","unstructured":"Lu D, Qiao Y, Brown NE, Wang J. Racial and ethnic disparities in influenza vaccination among adults with chronic medical conditions vary by age in the United States. PLoS\u00a0One. 2017;12(1): e0169679. https:\/\/doi.org\/10.1371\/journal.pone.0169679.","journal-title":"PLoS\u00a0One"},{"key":"1169_CR11","unstructured":"CDC. About estimated flu burden, Flu Burden. Accessed: Oct. 06, 2024 [Online]. https:\/\/www.cdc.gov\/flu-burden\/php\/about\/index.html."},{"issue":"1","key":"1169_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12979-020-00181-1","volume":"17","author":"JE McElhaney","year":"2020","unstructured":"McElhaney JE, Verschoor CP, Andrew MK, Haynes L, Kuchel GA, Pawelec G. The immune response to influenza in older humans: beyond immune senescence. Immun Ageing. 2020;17(1):10. https:\/\/doi.org\/10.1186\/s12979-020-00181-1.","journal-title":"Immun Ageing"},{"issue":"10127","key":"1169_CR13","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","volume":"391","author":"AD Iuliano","year":"2018","unstructured":"Iuliano AD, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285\u2013300. https:\/\/doi.org\/10.1016\/S0140-6736(17)33293-2.","journal-title":"Lancet"},{"issue":"2","key":"1169_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1001\/jama.289.2.179","volume":"289","author":"WW Thompson","year":"2003","unstructured":"Thompson WW, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179\u201386. https:\/\/doi.org\/10.1001\/jama.289.2.179.","journal-title":"JAMA"},{"issue":"11","key":"1169_CR15","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1001\/jama.292.11.1333","volume":"292","author":"WW Thompson","year":"2004","unstructured":"Thompson WW, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292(11):1333\u201340. https:\/\/doi.org\/10.1001\/jama.292.11.1333.","journal-title":"JAMA"},{"issue":"1","key":"1169_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/epirev\/mxz008","volume":"41","author":"K Dave","year":"2019","unstructured":"Dave K, Lee PC. Global geographical and temporal patterns of seasonal influenza and associated climatic factors. Epidemiol Rev. 2019;41(1):51\u201368. https:\/\/doi.org\/10.1093\/epirev\/mxz008.","journal-title":"Epidemiol Rev"},{"issue":"12","key":"1169_CR17","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a038356","volume":"11","author":"S Ryu","year":"2021","unstructured":"Ryu S, Cowling BJ. Human influenza epidemiology. Cold Spring Harb Perspect Med. 2021;11(12): a038356. https:\/\/doi.org\/10.1101\/cshperspect.a038356.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"11","key":"1169_CR18","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1017\/ice.2015.170","volume":"36","author":"NS Shah","year":"2015","unstructured":"Shah NS, et al. Severe influenza in 33 US Hospitals, 2013\u20132014: complications and risk factors for death in 507 patients. Infect Control Hosp Epidemiol. 2015;36(11):1251\u201360. https:\/\/doi.org\/10.1017\/ice.2015.170.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"12","key":"1169_CR19","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.mpmed.2021.09.015","volume":"49","author":"CSb Tyrrell","year":"2021","unstructured":"Tyrrell CSb, Allen JLY, Gkrania-Klotsas E. Influenza: epidemiology and hospital management. Medicine (Baltimore). 2021;49(12):797\u2013804. https:\/\/doi.org\/10.1016\/j.mpmed.2021.09.015.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1169_CR20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s13054-019-2539-x","volume":"23","author":"AC Kalil","year":"2019","unstructured":"Kalil AC, Thomas PG. Influenza virus-related critical illness: pathophysiology and epidemiology. Crit Care. 2019;23(1):258. https:\/\/doi.org\/10.1186\/s13054-019-2539-x.","journal-title":"Crit Care"},{"issue":"2","key":"1169_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1750-2659.2012.00360.x","volume":"7","author":"CC Blyth","year":"2013","unstructured":"Blyth CC, et al. The impact of bacterial and viral co-infection in severe influenza: co-infection in severe influenza. Influenza Other Respir Viruses. 2013;7(2):168\u201376. https:\/\/doi.org\/10.1111\/j.1750-2659.2012.00360.x.","journal-title":"Influenza Other Respir Viruses"},{"key":"1169_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2022.154164","volume":"72","author":"W-C Lee","year":"2022","unstructured":"Lee W-C, et al. The impacts of bacterial co-infections and secondary bacterial infections on patients with severe influenza pneumonitis admitted to the intensive care units. J Crit Care. 2022;72: 154164. https:\/\/doi.org\/10.1016\/j.jcrc.2022.154164.","journal-title":"J Crit Care"},{"issue":"s2","key":"1169_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/irv.12089","volume":"7","author":"C Joseph","year":"2013","unstructured":"Joseph C, Togawa Y, Shindo N. Bacterial and viral infections associated with influenza. Influenza Other Respir Viruses. 2013;7(s2):105\u201313. https:\/\/doi.org\/10.1111\/irv.12089.","journal-title":"Influenza Other Respir Viruses"},{"issue":"4","key":"1169_CR24","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s12325-023-02432-1","volume":"40","author":"J Langer","year":"2023","unstructured":"Langer J, et al. High clinical burden of influenza disease in adults aged \u2265 65 years: can we do better? a systematic literature review. Adv Ther. 2023;40(4):1601\u201327. https:\/\/doi.org\/10.1007\/s12325-023-02432-1.","journal-title":"Adv Ther"},{"key":"1169_CR25","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1186\/s12913-022-08586-y","volume":"22","author":"AM Near","year":"2022","unstructured":"Near AM, Tse J, Young-Xu Y, Hong DK, Reyes CM. Burden of influenza hospitalization among high-risk groups in the United States. BMC Health Serv Res. 2022;22:1209. https:\/\/doi.org\/10.1186\/s12913-022-08586-y.","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"1169_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1056\/NEJMoa1702090","volume":"378","author":"JC Kwong","year":"2018","unstructured":"Kwong JC, et al. Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med. 2018;378(4):345\u201353.","journal-title":"N Engl J Med"},{"key":"1169_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/B978-0-323-55435-0.00003-3","volume-title":"Vaccinations","author":"E Saade","year":"2019","unstructured":"Saade E, Canaday DH, Davidson HE, Han LF, Gravenstein S. Chapter 3\u2014special considerations for vaccines and older. In: Poland GA, editor. Vaccinations. Amsterdam: Elsevier; 2019. p. 35\u201353. https:\/\/doi.org\/10.1016\/B978-0-323-55435-0.00003-3."},{"issue":"7","key":"1169_CR28","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41579-021-00542-7","volume":"19","author":"T Flerlage","year":"2021","unstructured":"Flerlage T, Boyd DF, Meliopoulos V, Thomas PG, Schultz-Cherry S. Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract. Nat Rev Microbiol. 2021;19(7):425\u201341. https:\/\/doi.org\/10.1038\/s41579-021-00542-7.","journal-title":"Nat Rev Microbiol"},{"key":"1169_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.942796","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Dong C, Han Y, Gu Z, Sun C. Immunosenescence, aging and successful aging. Front Immunol. 2022;13: 942796. https:\/\/doi.org\/10.3389\/fimmu.2022.942796.","journal-title":"Front Immunol"},{"key":"1169_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2022.900028","volume":"3","author":"K-A Lee","year":"2022","unstructured":"Lee K-A, Flores RR, Jang IH, Saathoff A, Robbins PD. Immune senescence, immunosenescence and aging. Front Aging. 2022;3: 900028. https:\/\/doi.org\/10.3389\/fragi.2022.900028.","journal-title":"Front Aging"},{"key":"1169_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i6258","author":"S Ghebrehewet","year":"2016","unstructured":"Ghebrehewet S, MacPherson P, Ho A. Influenza. BMJ. 2016. https:\/\/doi.org\/10.1136\/bmj.i6258.","journal-title":"BMJ"},{"issue":"9186","key":"1169_CR32","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/S0140-6736(99)01241-6","volume":"354","author":"NJ Cox","year":"1999","unstructured":"Cox NJ, Subbarao K. Influenza. Lancet. 1999;354(9186):1277\u201382. https:\/\/doi.org\/10.1016\/S0140-6736(99)01241-6.","journal-title":"Lancet"},{"key":"1169_CR33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1471-2334-11-140","volume":"11","author":"S Meschi","year":"2011","unstructured":"Meschi S, et al. Duration of viral shedding in hospitalized patients infected with pandemic H1N1. BMC Infect Dis. 2011;11:140. https:\/\/doi.org\/10.1186\/1471-2334-11-140.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"1169_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.408","volume":"4","author":"V Phetcharakupt","year":"2021","unstructured":"Phetcharakupt V, Pasomsub E, Kiertiburanakul S. Clinical manifestations of influenza and performance of rapid influenza diagnostic test: a university hospital setting. Health Sci Rep. 2021;4(4): e408. https:\/\/doi.org\/10.1002\/hsr2.408.","journal-title":"Health Sci Rep"},{"issue":"44","key":"1169_CR35","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001952","volume":"94","author":"J-H Yang","year":"2015","unstructured":"Yang J-H, et al. Predictive symptoms and signs of laboratory-confirmed influenza. Medicine (Baltimore). 2015;94(44): e1952. https:\/\/doi.org\/10.1097\/MD.0000000000001952.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"1169_CR36","doi-asserted-by":"publisher","first-page":"567","DOI":"10.18926\/AMO\/62769","volume":"75","author":"R Takase","year":"2021","unstructured":"Takase R, et al. Clinical manifestations of patients with influenza differ by age\u202f: a prospective, multi-centered study in the Setouchi marine area. Acta Med Okayama. 2021;75(5):567\u201374. https:\/\/doi.org\/10.18926\/AMO\/62769.","journal-title":"Acta Med Okayama"},{"issue":"6","key":"1169_CR37","doi-asserted-by":"publisher","first-page":"e535","DOI":"10.1111\/j.1750-2659.2011.00269.x","volume":"5","author":"JY Song","year":"2011","unstructured":"Song JY, et al. Clinical, laboratory and radiologic characteristics of 2009 pandemic influenza A\/H1N1 pneumonia: primary influenza pneumonia versus concomitant\/secondary bacterial pneumonia. Influenza Other Respir Viruses. 2011;5(6):e535\u201343. https:\/\/doi.org\/10.1111\/j.1750-2659.2011.00269.x.","journal-title":"Influenza Other Respir Viruses"},{"issue":"5","key":"1169_CR38","doi-asserted-by":"publisher","first-page":"R148","DOI":"10.1186\/cc8044","volume":"13","author":"J Rello","year":"2009","unstructured":"Rello J, et al. Intensive care adult patients with severe respiratory failure caused by influenza A (H1N1)v in Spain. Crit Care. 2009;13(5):R148. https:\/\/doi.org\/10.1186\/cc8044.","journal-title":"Crit Care"},{"key":"1169_CR39","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ijid.2020.04.013","volume":"95","author":"W-D Liu","year":"2020","unstructured":"Liu W-D, Yeh C-Y, Shih M-C, Sheng W-H. Clinical manifestations and risk factors for mortality of patients with severe influenza during the 2016\u20132018 season. Int J Infect Dis. 2020;95:347\u201351. https:\/\/doi.org\/10.1016\/j.ijid.2020.04.013.","journal-title":"Int J Infect Dis"},{"issue":"10","key":"1169_CR40","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1099\/jmm.0.000593","volume":"66","author":"C-M Chao","year":"2017","unstructured":"Chao C-M, et al. Outcomes of patients with severe influenza infection admitted to intensive care units: a retrospective study in a medical centre. J Med Microbiol. 2017;66(10):1421\u20138. https:\/\/doi.org\/10.1099\/jmm.0.000593.","journal-title":"J Med Microbiol"},{"issue":"1","key":"1169_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210353","volume":"14","author":"A Mart\u00ednez","year":"2019","unstructured":"Mart\u00ednez A, et al. Risk factors associated with severe outcomes in adult hospitalized patients according to influenza type and subtype. PLoS\u00a0One. 2019;14(1): e0210353. https:\/\/doi.org\/10.1371\/journal.pone.0210353.","journal-title":"PLoS\u00a0One"},{"issue":"3","key":"1169_CR42","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jiac.2020.10.021","volume":"27","author":"T Ishida","year":"2021","unstructured":"Ishida T, et al. Clinical manifestations of adult patients requiring influenza-associated hospitalization: a prospective multicenter cohort study in Japan via internet surveillance. J Infect Chemother. 2021;27(3):480\u20135. https:\/\/doi.org\/10.1016\/j.jiac.2020.10.021.","journal-title":"J Infect Chemother"},{"issue":"5","key":"1169_CR43","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/jgf2.431","volume":"22","author":"H Takeoka","year":"2021","unstructured":"Takeoka H, et al. Useful clinical findings and simple laboratory data for the diagnosis of seasonal influenza. J Gen Fam Med. 2021;22(5):231\u20136. https:\/\/doi.org\/10.1002\/jgf2.431.","journal-title":"J Gen Fam Med"},{"issue":"5","key":"1169_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23191","volume":"34","author":"Q Han","year":"2020","unstructured":"Han Q, et al. Role of hematological parameters in the diagnosis of influenza virus infection in patients with respiratory tract infection symptoms. J Clin Lab Anal. 2020;34(5): e23191. https:\/\/doi.org\/10.1002\/jcla.23191.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"1169_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ejcdt.2015.07.001","volume":"65","author":"M Abdelsalam","year":"2016","unstructured":"Abdelsalam M, Diab HS, Ragab Y. Radiological findings in patients with H1N1 influenza pneumonia. Egypt J Chest Dis Tuberc. 2016;65(1):135\u201342. https:\/\/doi.org\/10.1016\/j.ejcdt.2015.07.001.","journal-title":"Egypt J Chest Dis Tuberc"},{"issue":"5","key":"1169_CR46","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/MCC.0000000000000638","volume":"25","author":"C Sarda","year":"2019","unstructured":"Sarda C, Palma P, Rello J. Severe influenza: overview in critically ill patients. Curr Opin Crit Care. 2019;25(5):449\u201357. https:\/\/doi.org\/10.1097\/MCC.0000000000000638.","journal-title":"Curr Opin Crit Care"},{"key":"1169_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2019.103992","volume":"345","author":"SR Keilich","year":"2019","unstructured":"Keilich SR, Bartley JM, Haynes L. Diminished immune responses with aging predispose older adults to common and uncommon influenza complications. Cell Immunol. 2019;345: 103992. https:\/\/doi.org\/10.1016\/j.cellimm.2019.103992.","journal-title":"Cell Immunol"},{"issue":"1","key":"1169_CR48","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.idc.2022.11.005","volume":"37","author":"M Al-Jabri","year":"2023","unstructured":"Al-Jabri M, Rosero C, Saade EA. Vaccine-preventable diseases in older adults. Infect Dis Clin North Am. 2023;37(1):103\u201321. https:\/\/doi.org\/10.1016\/j.idc.2022.11.005.","journal-title":"Infect Dis Clin North Am"},{"key":"1169_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101422","volume":"71","author":"A Santoro","year":"2021","unstructured":"Santoro A, Bientinesi E, Monti D. Immunosenescence and inflammaging in the aging process: age-related diseases or longevity? Ageing Res Rev. 2021;71: 101422. https:\/\/doi.org\/10.1016\/j.arr.2021.101422.","journal-title":"Ageing Res Rev"},{"key":"1169_CR50","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.2147\/IDR.S305509","volume":"14","author":"L Chen","year":"2021","unstructured":"Chen L, Han X, Li Y, Zhang C, Xing X. Complications of cardiovascular events in patients hospitalized with influenza-related pneumonia. Infect Drug Resist. 2021;14:1363\u201373. https:\/\/doi.org\/10.2147\/IDR.S305509.","journal-title":"Infect Drug Resist"},{"issue":"8","key":"1169_CR51","doi-asserted-by":"publisher","first-page":"605","DOI":"10.7326\/M20-1509","volume":"173","author":"EJ Chow","year":"2020","unstructured":"Chow EJ, et al. Acute cardiovascular events associated with influenza in hospitalized adults: a cross-sectional study. Ann Intern Med. 2020;173(8):605\u201313. https:\/\/doi.org\/10.7326\/M20-1509.","journal-title":"Ann Intern Med"},{"issue":"24","key":"1169_CR52","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1136\/heartjnl-2016-309983","volume":"102","author":"CR MacIntyre","year":"2016","unstructured":"MacIntyre CR, Mahimbo A, Moa AM, Barnes M. Influenza vaccine as a coronary intervention for prevention of myocardial infarction. Heart Br Card Soc. 2016;102(24):1953\u20136. https:\/\/doi.org\/10.1136\/heartjnl-2016-309983.","journal-title":"Heart Br Card Soc"},{"issue":"2","key":"1169_CR53","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00381-017-3554-3","volume":"34","author":"MS Paksu","year":"2018","unstructured":"Paksu MS, et al. Neuroinfluenza: evaluation of seasonal influenza associated severe neurological complications in children (a multicenter study). Childs Nerv Syst. 2018;34(2):335\u201347. https:\/\/doi.org\/10.1007\/s00381-017-3554-3.","journal-title":"Childs Nerv Syst"},{"issue":"4","key":"1169_CR54","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/cid\/cis454","volume":"55","author":"CA Glaser","year":"2012","unstructured":"Glaser CA, et al. A Population-based study of neurologic manifestations of severe influenza A(H1N1)pdm09 in California. Clin Infect Dis. 2012;55(4):514\u201320. https:\/\/doi.org\/10.1093\/cid\/cis454.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1169_CR55","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/ccr3.1353","volume":"6","author":"B Kheiri","year":"2018","unstructured":"Kheiri B, Abu Sitta E, Salih A, Al Qasmi M, Bachuwa G. Acute disseminated encephalomyelitis following influenza A pneumonia. Clin Case Rep. 2018;6(2):436\u20138. https:\/\/doi.org\/10.1002\/ccr3.1353.","journal-title":"Clin Case Rep"},{"issue":"1","key":"1169_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1916","volume":"11","author":"D Radzi\u0161auskien\u0117","year":"2020","unstructured":"Radzi\u0161auskien\u0117 D, Vitkauskait\u0117 M, \u017dvinyt\u0117 K, Mameni\u0161kien\u0117 R. Neurological complications of pandemic A(H1N1)2009pdm, postpandemic A(H1N1)v, and seasonal influenza A. Brain Behav. 2020;11(1): e01916. https:\/\/doi.org\/10.1002\/brb3.1916.","journal-title":"Brain Behav"},{"key":"1169_CR57","doi-asserted-by":"publisher","DOI":"10.1099\/jmmcr.0.005076","author":"WJ Meijer","year":"2016","unstructured":"Meijer WJ, et al. Acute influenza virus-associated encephalitis and encephalopathy in adults: a challenging diagnosis. JMM Case Rep. 2016. https:\/\/doi.org\/10.1099\/jmmcr.0.005076.","journal-title":"JMM Case Rep"},{"issue":"3","key":"1169_CR58","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.tmaid.2008.03.003","volume":"6","author":"S Toovey","year":"2008","unstructured":"Toovey S. Influenza-associated central nervous system dysfunction: a literature review. Travel Med Infect Dis. 2008;6(3):114\u201324. https:\/\/doi.org\/10.1016\/j.tmaid.2008.03.003.","journal-title":"Travel Med Infect Dis"},{"issue":"6","key":"1169_CR59","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/cid\/cit922","volume":"58","author":"A Goenka","year":"2014","unstructured":"Goenka A, et al. Neurological manifestations of influenza infection in children and adults: results of a National British Surveillance Study. Clin Infect Dis. 2014;58(6):775\u201384. https:\/\/doi.org\/10.1093\/cid\/cit922.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1169_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000344","volume":"2","author":"CC Tam","year":"2007","unstructured":"Tam CC, O\u2019Brien SJ, Petersen I, Islam A, Hayward A, Rodrigues LC. Guillain\u2013Barr\u00e9 syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the General Practice Research Database. PLoS\u00a0One. 2007;2(4): e344. https:\/\/doi.org\/10.1371\/journal.pone.0000344.","journal-title":"PLoS\u00a0One"},{"issue":"3","key":"1169_CR61","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/aje\/kwn310","volume":"169","author":"J Stowe","year":"2008","unstructured":"Stowe J, Andrews N, Wise L, Miller E. Investigation of the temporal association of Guillain\u2013Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database. Am J Epidemiol. 2008;169(3):382\u20138. https:\/\/doi.org\/10.1093\/aje\/kwn310.","journal-title":"Am J Epidemiol"},{"issue":"12","key":"1169_CR62","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.3201\/eid1212.051032","volume":"12","author":"C Tam","year":"2006","unstructured":"Tam C, O\u2019Brien S, Rodrigues L. Influenza, Campylobacter and Mycoplasma infections, and hospital admissions for Guillain\u2013Barr\u00e9 syndrome, England. Emerg Infect Dis. 2006;12(12):1880\u20137. https:\/\/doi.org\/10.3201\/eid1212.051032.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"1169_CR63","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1086\/594124","volume":"48","author":"V Sivadon-Tardy","year":"2009","unstructured":"Sivadon-Tardy V, et al. Guillain\u2013Barr\u00e9 Syndrome and influenza virus infection. Clin Infect Dis. 2009;48(1):48\u201356. https:\/\/doi.org\/10.1086\/594124.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1169_CR64","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00431-020-03835-w","volume":"180","author":"J Kerr","year":"2021","unstructured":"Kerr J, Macartney K, Britton PN. Influenza-associated myositis: a single-centre, 5-year retrospective study. Eur J Pediatr. 2021;180(2):577\u201384. https:\/\/doi.org\/10.1007\/s00431-020-03835-w.","journal-title":"Eur J Pediatr"},{"issue":"11","key":"1169_CR65","first-page":"2276","volume":"58","author":"H Ozawa","year":"2000","unstructured":"Ozawa H, Noma S, Nonaka I. Myositis and rhabdomyolysis with influenza infection. Nihon Rinsho Jpn J Clin Med. 2000;58(11):2276\u201381.","journal-title":"Nihon Rinsho Jpn J Clin Med"},{"issue":"3","key":"1169_CR66","doi-asserted-by":"publisher","first-page":"166","DOI":"10.5414\/cnp66166","volume":"66","author":"M Abe","year":"2006","unstructured":"Abe M, Higuchi T, Okada K, Kaizu K, Matsumoto K. Clinical study of influenza-associated rhabdomyolysis with acute renal failure. Clin Nephrol. 2006;66(3):166\u201370. https:\/\/doi.org\/10.5414\/cnp66166.","journal-title":"Clin Nephrol"},{"issue":"7","key":"1169_CR67","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1007\/s00134-012-2565-5","volume":"38","author":"B Borgatta","year":"2012","unstructured":"Borgatta B, et al. Elevation of creatine kinase is associated with worse outcomes in 2009 pH1N1 influenza A infection. Intensive Care Med. 2012;38(7):1152\u201361. https:\/\/doi.org\/10.1007\/s00134-012-2565-5.","journal-title":"Intensive Care Med"},{"issue":"1","key":"1169_CR68","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/1471-2369-14-123","volume":"14","author":"SM Bagshaw","year":"2013","unstructured":"Bagshaw SM, Sood MM, Long J, Fowler RA, Adhikari NK, Canadian Critical Care Trials Group H1N1 Collaborative. Acute kidney injury among critically ill patients with pandemic H1N1 influenza A in Canada: cohort study. BMC Nephrol. 2013;14(1):123. https:\/\/doi.org\/10.1186\/1471-2369-14-123.","journal-title":"BMC Nephrol"},{"issue":"1","key":"1169_CR69","doi-asserted-by":"publisher","first-page":"S1399","DOI":"10.14309\/01.ajg.0000712736.60332.3c","volume":"115","author":"T Alhobayb","year":"2020","unstructured":"Alhobayb T, Ismail M, De Lancy S, Sclair S. S2672 Influenza a virus as a trigger for autoimmune hepatitis. Am J Gastroenterol. 2020;115(1):S1399\u2013400. https:\/\/doi.org\/10.14309\/01.ajg.0000712736.60332.3c.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"1169_CR70","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1111\/j.1750-2659.2011.00287.x","volume":"6","author":"N Papic","year":"2012","unstructured":"Papic N, Pangercic A, Vargovic M, Barsic B, Vince A, Kuzman I. Liver involvement during influenza infection: perspective on the 2009 influenza pandemic: liver involvement during influenza infection. Influenza Other Respir Viruses. 2012;6(3):e2\u20135. https:\/\/doi.org\/10.1111\/j.1750-2659.2011.00287.x.","journal-title":"Influenza Other Respir Viruses"},{"issue":"2","key":"1169_CR71","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.oret.2017.09.020","volume":"2","author":"AK Durrani","year":"2018","unstructured":"Durrani AK, Mehta VJ, Kim SJ. Postinfluenza Purtscher-like retinopathy with acute macular neuroretinopathy. Ophthalmol Retina. 2018;2(2):95. https:\/\/doi.org\/10.1016\/j.oret.2017.09.020.","journal-title":"Ophthalmol Retina"},{"issue":"7","key":"1169_CR72","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/s00347-003-0899-7","volume":"101","author":"HOC G\u00fcmbel","year":"2004","unstructured":"G\u00fcmbel HOC, Lipke KJ, Sch\u00e4fer H-G, Cinatl I, Hattenbach LO. Beidseitige Panuveitis nach einer influenza-A-grippe und therapie mit amantadin und hyperimmunglobulinen. Ophthalmology. 2004;101(7):720\u20135. https:\/\/doi.org\/10.1007\/s00347-003-0899-7.","journal-title":"Ophthalmology"},{"issue":"3","key":"1169_CR73","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000337138","volume":"48","author":"DEAA Mansour","year":"2012","unstructured":"Mansour DEAA, El-Shazly AA-F, Elawamry AI, Ismail AT. Comparison of ocular findings in patients with H1N1 influenza infection versus patients receiving influenza vaccine during a pandemic. Ophthalmic Res. 2012;48(3):134\u20138. https:\/\/doi.org\/10.1159\/000337138.","journal-title":"Ophthalmic Res"},{"issue":"1","key":"1169_CR74","first-page":"35","volume":"31","author":"VM Villegas","year":"2012","unstructured":"Villegas VM, Monagas M, Rivera L, Santos C, Serrano L. Visual loss associated with influenza A: a case report and review of literature. P R Health Sci J. 2012;31(1):35\u20137.","journal-title":"P R Health Sci J"},{"issue":"3","key":"1169_CR75","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/WNO.0000000000000247","volume":"35","author":"DA Breker","year":"2015","unstructured":"Breker DA, Stacey AW, Srinivasan A, Bursztyn LLCD, Trobe JD, Johnson MW. Vision loss caused by retinal and lateral geniculate nucleus infarction in H1N1 influenza. J Neuroophthalmol. 2015;35(3):265\u20139. https:\/\/doi.org\/10.1097\/WNO.0000000000000247.","journal-title":"J Neuroophthalmol"},{"issue":"8","key":"1169_CR76","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29010","volume":"95","author":"G Moreno","year":"2023","unstructured":"Moreno G, et al. Effectiveness of prolonged versus standard-course of oseltamivir in critically ill patients with severe influenza infection: a multicentre cohort study. J Med Virol. 2023;95(8): e29010. https:\/\/doi.org\/10.1002\/jmv.29010.","journal-title":"J Med Virol"},{"issue":"6","key":"1169_CR77","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/cid\/ciy874","volume":"68","author":"TM Uyeki","year":"2019","unstructured":"Uyeki TM, et al. Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clin Infect Dis. 2019;68(6):895\u2013902. https:\/\/doi.org\/10.1093\/cid\/ciy874.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1169_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121952","volume":"10","author":"ML Lindegren","year":"2015","unstructured":"Lindegren ML, et al. antiviral treatment among older adults hospitalized with influenza, 2006\u20132012. PLoS\u00a0One. 2015;10(3): e0121952. https:\/\/doi.org\/10.1371\/journal.pone.0121952.","journal-title":"PLoS\u00a0One"},{"key":"1169_CR79","unstructured":"Influenza Antiviral Drug Resistance | CDC [Online]. https:\/\/www.cdc.gov\/flu\/treatment\/antiviralresistance.htm. Accessed Dec 11, 2023."},{"issue":"1","key":"1169_CR80","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1186\/s12879-021-06812-2","volume":"21","author":"TL Wiemken","year":"2021","unstructured":"Wiemken TL, et al. Effectiveness of oseltamivir treatment on clinical failure in hospitalized patients with lower respiratory tract infection. BMC Infect Dis. Oct.2021;21(1):1106. https:\/\/doi.org\/10.1186\/s12879-021-06812-2.","journal-title":"BMC Infect Dis"},{"issue":"44","key":"1169_CR81","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2019.24.44.1900087","volume":"24","author":"M Reacher","year":"2019","unstructured":"Reacher M, et al. Influenza-associated mortality in hospital care: a retrospective cohort study of risk factors and impact of oseltamivir in an English teaching hospital, 2016 to 2017. Eurosurveillance. 2019;24(44): 1900087. https:\/\/doi.org\/10.2807\/1560-7917.ES.2019.24.44.1900087.","journal-title":"Eurosurveillance"},{"issue":"1","key":"1169_CR82","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/cid\/ciy860","volume":"69","author":"J Katzen","year":"2019","unstructured":"Katzen J, Kohn R, Houk JL, Ison MG. Early oseltamivir after hospital admission is associated with shortened hospitalization: a 5-year analysis of oseltamivir timing and clinical outcomes. Clin Infect Dis Off Publ Infect Dis Soc Am. 2019;69(1):52\u20138. https:\/\/doi.org\/10.1093\/cid\/ciy860.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"5","key":"1169_CR83","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1093\/jac\/dkr089","volume":"66","author":"V Hiba","year":"2011","unstructured":"Hiba V, Chowers M, Levi-Vinograd I, Rubinovitch B, Leibovici L, Paul M. Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): retrospective cohort study. J Antimicrob Chemother. 2011;66(5):1150\u20135. https:\/\/doi.org\/10.1093\/jac\/dkr089.","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"1169_CR84","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1097\/INF.0b013e318232ede9","volume":"30","author":"SE Coffin","year":"2011","unstructured":"Coffin SE, Leckerman K, Keren R, Hall M, Localio R, Zaoutis TE. Oseltamivir shortens hospital stays of critically ill children hospitalized with seasonal influenza: a retrospective cohort study. Pediatr Infect Dis J. 2011;30(11):962\u20136. https:\/\/doi.org\/10.1097\/INF.0b013e318232ede9.","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"1169_CR85","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1378\/chest.10-2792","volume":"140","author":"D Viasus","year":"2011","unstructured":"Viasus D, et al. Timing of oseltamivir administration and outcomes in hospitalized adults with pandemic 2009 influenza A(H1N1) virus infection. Chest. 2011;140(4):1025\u201332. https:\/\/doi.org\/10.1378\/chest.10-2792.","journal-title":"Chest"},{"issue":"3","key":"1169_CR86","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-2608","volume":"143","author":"R Miyakawa","year":"2019","unstructured":"Miyakawa R, Barreto NB, Kato RM, Neely MN, Russell CJ. Early use of anti-influenza medications in hospitalized children with tracheostomy. Pediatrics. 2019;143(3): e20182608. https:\/\/doi.org\/10.1542\/peds.2018-2608.","journal-title":"Pediatrics"},{"issue":"11","key":"1169_CR87","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1093\/cid\/ciz101","volume":"69","author":"T Lytras","year":"2019","unstructured":"Lytras T, Mouratidou E, Andreopoulou A, Bonovas S, Tsiodras S. Effect of early oseltamivir treatment on mortality in critically ill patients with different types of influenza: a multiseason cohort study. Clin Infect Dis Off Publ Infect Dis Soc Am. 2019;69(11):1896\u2013902. https:\/\/doi.org\/10.1093\/cid\/ciz101.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"4","key":"1169_CR88","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-050417","volume":"148","author":"AP Campbell","year":"2021","unstructured":"Campbell AP, et al. Influenza antiviral treatment and length of stay. Pediatrics. 2021;148(4): e2021050417. https:\/\/doi.org\/10.1542\/peds.2021-050417.","journal-title":"Pediatrics"},{"issue":"7","key":"1169_CR89","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s10096-020-03835-6","volume":"39","author":"L Chen","year":"2020","unstructured":"Chen L, Han X, Li Y, Zhang C, Xing X. Impact of early neuraminidase inhibitor treatment on clinical outcomes in patients with influenza B-related pneumonia: a multicenter cohort study. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2020;39(7):1231\u20138. https:\/\/doi.org\/10.1007\/s10096-020-03835-6.","journal-title":"Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol"},{"issue":"6","key":"1169_CR90","doi-asserted-by":"publisher","first-page":"e1539","DOI":"10.1542\/peds.2013-2149","volume":"132","author":"JK Louie","year":"2013","unstructured":"Louie JK, Yang S, Samuel MC, Uyeki TM, Schechter R. Neuraminidase inhibitors for critically ill children with influenza. Pediatrics. 2013;132(6):e1539-1545. https:\/\/doi.org\/10.1542\/peds.2013-2149.","journal-title":"Pediatrics"},{"issue":"5","key":"1169_CR91","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S2213-2600(14)70041-4","volume":"2","author":"SG Muthuri","year":"2014","unstructured":"Muthuri SG, et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med. 2014;2(5):395\u2013404. https:\/\/doi.org\/10.1016\/S2213-2600(14)70041-4.","journal-title":"Lancet Respir Med"},{"issue":"3","key":"1169_CR92","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/infdis\/jiz152","volume":"221","author":"S Venkatesan","year":"2020","unstructured":"Venkatesan S, et al. Neuraminidase inhibitors and hospital length of stay: a meta-analysis of individual participant data to determine treatment effectiveness among patients hospitalized with nonfatal 2009 pandemic influenza A(H1N1) virus infection. J Infect Dis. 2020;221(3):356\u201366. https:\/\/doi.org\/10.1093\/infdis\/jiz152.","journal-title":"J Infect Dis"},{"issue":"12","key":"1169_CR93","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1086\/523584","volume":"45","author":"A McGeer","year":"2007","unstructured":"McGeer A, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis Off Publ Infect Dis Soc Am. 2007;45(12):1568\u201375. https:\/\/doi.org\/10.1086\/523584.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"1169_CR94","doi-asserted-by":"crossref","unstructured":"Heneghan, C. J. et al. Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data. NIHR Journals Library (2016).","DOI":"10.3310\/hta20420"},{"issue":"9","key":"1169_CR95","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s10096-017-2982-z","volume":"36","author":"S-H Choi","year":"2017","unstructured":"Choi S-H, Kim T, Park K-H, Kwak YG, Chung J-W, Lee MS. Early administration of neuraminidase inhibitors in adult patients hospitalized for influenza does not benefit survival: a retrospective cohort study. Eur J Clin Microbiol Infect Dis. 2017;36(9):1673\u20137. https:\/\/doi.org\/10.1007\/s10096-017-2982-z.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"1169_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160430","volume":"11","author":"M Wolkewitz","year":"2016","unstructured":"Wolkewitz M, Schumacher M. Neuraminidase inhibitors and hospital mortality in British patients with H1N1 influenza A: a re-analysis of observational data. PLoS\u00a0One. 2016;11(9): e0160430. https:\/\/doi.org\/10.1371\/journal.pone.0160430.","journal-title":"PLoS\u00a0One"},{"issue":"3","key":"1169_CR97","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1111\/bcp.14523","volume":"87","author":"S Sturm","year":"2021","unstructured":"Sturm S, et al. Pharmacologic effects of oseltamivir in immunocompromised adult patients as assessed by population PK\/PD analysis and drug-disease modelling for dosing regimen optimization. Br J Clin Pharmacol. 2021;87(3):1359\u201368. https:\/\/doi.org\/10.1111\/bcp.14523.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"1169_CR98","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1503\/cmaj.092127","volume":"182","author":"RE Ariano","year":"2010","unstructured":"Ariano RE, et al. Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza. CMAJ Can Med Assoc J. 2010;182(4):357\u201363. https:\/\/doi.org\/10.1503\/cmaj.092127.","journal-title":"CMAJ Can Med Assoc J"},{"issue":"11","key":"1169_CR99","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/cid\/cit597","volume":"57","author":"N Lee","year":"2013","unstructured":"Lee N, et al. A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza A and B infections. Clin Infect Dis Off Publ Infect Dis Soc Am. 2013;57(11):1511\u20139. https:\/\/doi.org\/10.1093\/cid\/cit597.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"1","key":"1169_CR100","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1600-6143.2009.02960.x","volume":"10","author":"D Kumar","year":"2010","unstructured":"Kumar D, et al. Guidance on novel influenza A\/H1N1 in solid organ transplant recipients. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2010;10(1):18\u201325. https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02960.x.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"issue":"10","key":"1169_CR101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003410","volume":"3","author":"WRJ Taylor","year":"2008","unstructured":"Taylor WRJ, et al. Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza. PLoS\u00a0One. 2008;3(10): e3410. https:\/\/doi.org\/10.1371\/journal.pone.0003410.","journal-title":"PLoS\u00a0One"},{"issue":"5","key":"1169_CR102","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00134-013-2851-x","volume":"39","author":"W Kromdijk","year":"2013","unstructured":"Kromdijk W, Sikma MA, van den Broek MPH, Beijnen JH, Huitema ADR, de Lange DW. Pharmacokinetics of oseltamivir carboxylate in critically ill patients: each patient is unique. Intensive Care Med. 2013;39(5):977\u20138. https:\/\/doi.org\/10.1007\/s00134-013-2851-x.","journal-title":"Intensive Care Med"},{"issue":"2","key":"1169_CR103","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/FTD.0b013e318248672c","volume":"34","author":"F Lemaitre","year":"2012","unstructured":"Lemaitre F, et al. Impact of extracorporeal membrane oxygenation and continuous venovenous hemodiafiltration on the pharmacokinetics of oseltamivir carboxylate in critically ill patients with pandemic (H1N1) influenza. Ther Drug Monit. 2012;34(2):171\u20135. https:\/\/doi.org\/10.1097\/FTD.0b013e318248672c.","journal-title":"Ther Drug Monit"},{"issue":"1","key":"1169_CR104","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1177\/0310057X1304100112","volume":"41","author":"H Mulla","year":"2013","unstructured":"Mulla H, Peek GJ, Harvey C, Westrope C, Kidy Z, Ramaiah R. Oseltamivir pharmacokinetics in critically ill adults receiving extracorporeal membrane oxygenation support. Anaesth Intensive Care. 2013;41(1):66\u201373. https:\/\/doi.org\/10.1177\/0310057X1304100112.","journal-title":"Anaesth Intensive Care"},{"issue":"9","key":"1169_CR105","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1093\/jac\/dkr257","volume":"66","author":"LM Thorne-Humphrey","year":"2011","unstructured":"Thorne-Humphrey LM, et al. Oseltamivir pharmacokinetics in morbid obesity (OPTIMO trial). J Antimicrob Chemother. 2011;66(9):2083\u201391. https:\/\/doi.org\/10.1093\/jac\/dkr257.","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"1169_CR106","doi-asserted-by":"publisher","first-page":"5640","DOI":"10.1128\/AAC.00422-11","volume":"55","author":"MP Pai","year":"2011","unstructured":"Pai MP, Lodise TP. Oseltamivir and oseltamivir carboxylate pharmacokinetics in obese adults: dose modification for weight is not necessary. Antimicrob Agents Chemother. 2011;55(12):5640\u20135. https:\/\/doi.org\/10.1128\/AAC.00422-11.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"1169_CR107","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1128\/AAC.01786-13","volume":"58","author":"P Jittamala","year":"2014","unstructured":"Jittamala P, et al. Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese Thai subjects. Antimicrob Agents Chemother. 2014;58(3):1615\u201321. https:\/\/doi.org\/10.1128\/AAC.01786-13.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"1169_CR108","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.1093\/cid\/ciu632","volume":"59","author":"MD de Jong","year":"2014","unstructured":"de Jong MD, et al. Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients. Clin Infect Dis Off Publ Infect Dis Soc Am. 2014;59(12):e172\u2013185. https:\/\/doi.org\/10.1093\/cid\/ciu632.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"4","key":"1169_CR109","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3851\/IMP2680","volume":"19","author":"MG Ison","year":"2014","unstructured":"Ison MG, et al. Intravenous peramivir for treatment of influenza in hospitalized patients. Antivir Ther. 2014;19(4):349\u201361. https:\/\/doi.org\/10.3851\/IMP2680.","journal-title":"Antivir Ther"},{"issue":"4","key":"1169_CR110","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3349\/ymj.2017.58.4.778","volume":"58","author":"J Lee","year":"2017","unstructured":"Lee J, Park JH, Jwa H, Kim YH. Comparison of efficacy of intravenous peramivir and oral oseltamivir for the treatment of influenza: systematic review and meta-analysis. Yonsei Med J. 2017;58(4):778\u201385. https:\/\/doi.org\/10.3349\/ymj.2017.58.4.778.","journal-title":"Yonsei Med J"},{"issue":"1","key":"1169_CR111","first-page":"9","volume":"44","author":"KE Ng","year":"2019","unstructured":"Ng KE. Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza. Pharm Ther. 2019;44(1):9\u201311.","journal-title":"Pharm Ther"},{"key":"1169_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100486","volume":"296","author":"B Todd","year":"2021","unstructured":"Todd B, Tchesnokov EP, G\u00f6tte M. The active form of the influenza cap-snatching endonuclease inhibitor baloxavir marboxil is a tight binding inhibitor. J Biol Chem. 2021;296:100486. https:\/\/doi.org\/10.1016\/j.jbc.2021.100486.","journal-title":"J Biol Chem"},{"issue":"10","key":"1169_CR113","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1056\/NEJMoa1716197","volume":"379","author":"FG Hayden","year":"2018","unstructured":"Hayden FG, et al. Baloxavir marboxil for uncomplicated influenza in adults and adolescents. N Engl J Med. 2018;379(10):913\u201323. https:\/\/doi.org\/10.1056\/NEJMoa1716197.","journal-title":"N Engl J Med"},{"issue":"9","key":"1169_CR114","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1086\/651605","volume":"50","author":"MJ Memoli","year":"2010","unstructured":"Memoli MJ, Hrabal RJ, Hassantoufighi A, Eichelberger MC, Taubenberger JK. Rapid selection of oseltamivir and peramivir resistant pandemic H1N1 during therapy in two immunocompromised hosts. Clin Infect Dis Off Publ Infect Dis Soc Am. 2010;50(9):1252\u20135. https:\/\/doi.org\/10.1086\/651605.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"3","key":"1169_CR115","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S1473-3099(11)70318-8","volume":"12","author":"AC Hurt","year":"2012","unstructured":"Hurt AC, et al. Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. Lancet Infect Dis. 2012;12(3):240\u20138. https:\/\/doi.org\/10.1016\/S1473-3099(11)70318-8.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"1169_CR116","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1111\/irv.12132","volume":"7","author":"E Takashita","year":"2013","unstructured":"Takashita E, et al. Characterization of neuraminidase inhibitor-resistant influenza A(H1N1)pdm09 viruses isolated in four seasons during pandemic and post-pandemic periods in Japan. Influenza Other Respir Viruses. 2013;7(6):1390\u20139. https:\/\/doi.org\/10.1111\/irv.12132.","journal-title":"Influenza Other Respir Viruses"},{"issue":"1","key":"1169_CR117","doi-asserted-by":"publisher","first-page":"20666","DOI":"10.2807\/1560-7917.ES2014.19.1.20666","volume":"19","author":"E Takashita","year":"2014","unstructured":"Takashita E, et al. A community cluster of influenza A(H1N1)pdm09 virus exhibiting cross-resistance to oseltamivir and peramivir in Japan, November to December 2013. Eurosurveillance. 2014;19(1):20666. https:\/\/doi.org\/10.2807\/1560-7917.ES2014.19.1.20666.","journal-title":"Eurosurveillance"},{"issue":"11","key":"1169_CR118","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1093\/infdis\/jiv288","volume":"212","author":"AG L\u2019Huillier","year":"2015","unstructured":"L\u2019Huillier AG, et al. E119D neuraminidase mutation conferring pan-resistance to neuraminidase inhibitors in an A(H1N1)pdm09 isolate from a stem-cell transplant recipient. J Infect Dis. 2015;212(11):1726\u201334. https:\/\/doi.org\/10.1093\/infdis\/jiv288.","journal-title":"J Infect Dis"},{"issue":"8","key":"1169_CR119","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1093\/infdis\/jiv245","volume":"212","author":"D Tamura","year":"2015","unstructured":"Tamura D, et al. Emergence of multidrug-resistant influenza A(H1N1)pdm09 virus variants in an immunocompromised child treated with oseltamivir and zanamivir. J Infect Dis. 2015;212(8):1209\u201313. https:\/\/doi.org\/10.1093\/infdis\/jiv245.","journal-title":"J Infect Dis"},{"issue":"5","key":"1169_CR120","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/S1473-3099(21)00469-2","volume":"22","author":"D Kumar","year":"2022","unstructured":"Kumar D, et al. Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial. Lancet Infect Dis. 2022;22(5):718\u201330. https:\/\/doi.org\/10.1016\/S1473-3099(21)00469-2.","journal-title":"Lancet Infect Dis"},{"key":"1169_CR121","unstructured":"Therapeutics and COVID-19: living guideline [Online]. https:\/\/www.who.int\/publications-detail-redirect\/WHO-2019-nCoV-therapeutics-2022.4. Accessed Sep 09, 2023."},{"issue":"1","key":"1169_CR122","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1055\/s-0042-1759778","volume":"44","author":"F Amati","year":"2023","unstructured":"Amati F, Tonutti A, Huston J, Cruz CSD. Glucocorticoid therapy in COVID-19. Semin Respir Crit Care Med. 2023;44(1):100\u201317. https:\/\/doi.org\/10.1055\/s-0042-1759778.","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"1169_CR123","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1097\/CCM.0000000000004093","volume":"48","author":"LE Lansbury","year":"2020","unstructured":"Lansbury LE, Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Shen Lim W. Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis. Crit Care Med. 2020;48(2):e98\u2013106. https:\/\/doi.org\/10.1097\/CCM.0000000000004093.","journal-title":"Crit Care Med"},{"key":"1169_CR124","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-023-07033-8","author":"I Martin-Loeches","year":"2023","unstructured":"Martin-Loeches I, et al. ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive Care Med. 2023. https:\/\/doi.org\/10.1007\/s00134-023-07033-8.","journal-title":"Intensive Care Med"},{"key":"1169_CR125","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.167464","author":"HA Vanderven","year":"2023","unstructured":"Vanderven HA, et al. Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza. JCI Insight. 2023. https:\/\/doi.org\/10.1172\/jci.insight.167464.","journal-title":"JCI Insight"},{"issue":"11","key":"1169_CR126","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S2213-2600(19)30253-X","volume":"7","author":"RT Davey","year":"2019","unstructured":"Davey RT, et al. Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial. Lancet Respir Med. 2019;7(11):951\u201363. https:\/\/doi.org\/10.1016\/S2213-2600(19)30253-X.","journal-title":"Lancet Respir Med"},{"issue":"11","key":"1169_CR127","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/S2213-2600(19)30199-7","volume":"7","author":"JH Beigel","year":"2019","unstructured":"Beigel JH, et al. Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial. Lancet Respir Med. 2019;7(11):941\u201350. https:\/\/doi.org\/10.1016\/S2213-2600(19)30199-7.","journal-title":"Lancet Respir Med"},{"issue":"7","key":"1169_CR128","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac216","volume":"9","author":"JM D\u00edez","year":"2022","unstructured":"D\u00edez JM, Casals D, Romero C, Gajardo R. Medicinal immunoglobulin g products (2020) show high infectivity neutralizing activity against seasonal influenza virus strains selected for future vaccines (2020\u20132022). Open Forum Infect Dis. 2022;9(7): ofac216. https:\/\/doi.org\/10.1093\/ofid\/ofac216.","journal-title":"Open Forum Infect Dis"},{"key":"1169_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.104562","volume":"170","author":"K Sedeyn","year":"2019","unstructured":"Sedeyn K, Saelens X. New antibody-based prevention and treatment options for influenza. Antiviral Res. Oct.2019;170: 104562. https:\/\/doi.org\/10.1016\/j.antiviral.2019.104562.","journal-title":"Antiviral Res"},{"key":"1169_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2022.101207","volume":"53","author":"X Sun","year":"2022","unstructured":"Sun X, Ling Z, Yang Z, Sun B. Broad neutralizing antibody-based strategies to tackle influenza. Curr Opin Virol. 2022;53: 101207. https:\/\/doi.org\/10.1016\/j.coviro.2022.101207.","journal-title":"Curr Opin Virol"},{"issue":"4","key":"1169_CR131","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04728-22","volume":"11","author":"M Piepenbrink","year":"2023","unstructured":"Piepenbrink M, et al. Highly cross-reactive and protective influenza A Virus H3N2 hemagglutinin- and neuraminidase-specific human monoclonal antibodies. Microbiol Spectr. 2023;11(4): e0472822. https:\/\/doi.org\/10.1128\/spectrum.04728-22.","journal-title":"Microbiol Spectr"},{"issue":"3","key":"1169_CR132","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s00134-009-1746-3","volume":"36","author":"PR Ingram","year":"2010","unstructured":"Ingram PR, Inglis T, Moxon D, Speers D. Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection. Intensive Care Med. 2010;36(3):528\u201332. https:\/\/doi.org\/10.1007\/s00134-009-1746-3.","journal-title":"Intensive Care Med"},{"issue":"2","key":"1169_CR133","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/cid\/cix317","volume":"65","author":"WH Self","year":"2017","unstructured":"Self WH, et al. Procalcitonin as a marker of etiology in adults hospitalized with community-acquired pneumonia. Clin Infect Dis. 2017;65(2):183\u201390. https:\/\/doi.org\/10.1093\/cid\/cix317.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"1169_CR134","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007498.pub3","volume":"10","author":"P Schuetz","year":"2017","unstructured":"Schuetz P, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2017;10(10): CD007498. https:\/\/doi.org\/10.1002\/14651858.CD007498.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1169_CR135","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","volume":"18","author":"P Schuetz","year":"2018","unstructured":"Schuetz P, et al. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2018;18(1):95\u2013107. https:\/\/doi.org\/10.1016\/S1473-3099(17)30592-3.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"1169_CR136","doi-asserted-by":"publisher","first-page":"201.e1","DOI":"10.1016\/j.amjmed.2017.08.039","volume":"131","author":"TL Walsh","year":"2018","unstructured":"Walsh TL, et al. Impact of procalcitonin guidance with an educational program on management of adults hospitalized with pneumonia. Am J Med. 2018;131(2):201.e1-201.e8. https:\/\/doi.org\/10.1016\/j.amjmed.2017.08.039.","journal-title":"Am J Med"},{"issue":"7","key":"1169_CR137","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, et al. Diagnosis and treatment of adults with community-acquired pneumonia. an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45\u201367. https:\/\/doi.org\/10.1164\/rccm.201908-1581ST.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"1169_CR138","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/S1473-3099(18)30215-9","volume":"18","author":"IS Kamat","year":"2018","unstructured":"Kamat IS, Ramachandran V, Eswaran H, Abers MS, Musher DM. Low procalcitonin, community acquired pneumonia, and antibiotic therapy. Lancet Infect Dis. 2018;18(5):496\u20137. https:\/\/doi.org\/10.1016\/S1473-3099(18)30215-9.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"1169_CR139","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciy866","volume":"68","author":"TM Uyeki","year":"2019","unstructured":"Uyeki TM, et al. Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clin Infect Dis. 2019;68(6):e1\u201347. https:\/\/doi.org\/10.1093\/cid\/ciy866.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1169_CR140","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1055\/s-0041-1736459","volume":"42","author":"TDY Reijnders","year":"2021","unstructured":"Reijnders TDY, Schuurman AR, van der Poll T. The immune response to respiratory viruses: from start to memory. Semin Respir Crit Care Med. 2021;42(6):759\u201370. https:\/\/doi.org\/10.1055\/s-0041-1736459.","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"1169_CR141","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.3233\/JAD-220361","volume":"88","author":"AS Bukhbinder","year":"2022","unstructured":"Bukhbinder AS, et al. Risk of Alzheimer\u2019s disease following influenza vaccination: a claims-based cohort study using propensity score matching. J Alzheimers Dis JAD. 2022;88(3):1061\u201374. https:\/\/doi.org\/10.3233\/JAD-220361.","journal-title":"J Alzheimers Dis JAD"},{"issue":"4","key":"1169_CR142","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/acn3.545","volume":"5","author":"AK Boehme","year":"2018","unstructured":"Boehme AK, Luna J, Kulick ER, Kamel H, Elkind MSV. Influenza-like illness as a trigger for ischemic stroke. Ann Clin Transl Neurol. 2018;5(4):456\u201363.","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"1169_CR143","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41541-024-00841-z","volume":"9","author":"H Zhao","year":"2024","unstructured":"Zhao H, et al. Prospective cohort study evaluating the association between influenza vaccination and neurodegenerative diseases. NPJ Vaccines. 2024;9(1):51. https:\/\/doi.org\/10.1038\/s41541-024-00841-z.","journal-title":"NPJ Vaccines"},{"issue":"6","key":"1169_CR144","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s40520-023-02409-8","volume":"35","author":"F Ecarnot","year":"2023","unstructured":"Ecarnot F, et al. Dementia, infections and vaccines: 30 years of controversy. Aging Clin Exp Res. 2023;35(6):1145\u201360. https:\/\/doi.org\/10.1007\/s40520-023-02409-8.","journal-title":"Aging Clin Exp Res"},{"issue":"5","key":"1169_CR145","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1093\/advances\/nmac052","volume":"13","author":"PC Calder","year":"2022","unstructured":"Calder PC, et al. Nutrition, immunosenescence, and infectious disease: an overview of the scientific evidence on micronutrients and on modulation of the gut microbiota. Adv Nutr Bethesda Md. 2022;13(5):S1\u201326. https:\/\/doi.org\/10.1093\/advances\/nmac052.","journal-title":"Adv Nutr Bethesda Md"},{"issue":"1 Pt B","key":"1169_CR146","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.imlet.2014.06.009","volume":"162","author":"K Haq","year":"2014","unstructured":"Haq K, McElhaney JE. Ageing and respiratory infections: the airway of ageing. Immunol Lett. 2014;162(1 Pt B):323\u20138. https:\/\/doi.org\/10.1016\/j.imlet.2014.06.009.","journal-title":"Immunol Lett"},{"key":"1169_CR147","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2022.818700","volume":"3","author":"JB Torrelles","year":"2022","unstructured":"Torrelles JB, Restrepo BI, Bai Y, Ross C, Schlesinger LS, Turner J. The impact of aging on the lung alveolar environment, predetermining susceptibility to respiratory infections. Front Aging. 2022;3: 818700. https:\/\/doi.org\/10.3389\/fragi.2022.818700.","journal-title":"Front Aging"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-024-01169-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-024-01169-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-024-01169-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T13:19:37Z","timestamp":1737206377000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-024-01169-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":147,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1169"],"URL":"https:\/\/doi.org\/10.1007\/s40266-024-01169-y","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"25 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work did not receive any specific funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"No original data or materials were used, and therefore, ethics approval and informed consent were not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability, ethics approval and informed consent"}},{"value":"C.R. and E.S. contributed to the conceptualization and writing of the manuscript and S.G. provided critical revisions and insights.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"C.R. declares no conflicts of interest. S.G. receives honoraria for speaking or consulting from several pharmaceutical companies, including Sanofi, Seqirus, Moderna, Novavax, GSK, Pfizer, Genentech, and has investigator-initiated grant funding from Sanofi, Pfizer, and Genentech. E.S. received speaker and presenter fees from Envision Pharma and Sanofi Pasteur, travel and lodging expenses from Johnson and Johnson and Sanofi Pasteur, and grant or research support from Protein Sciences Corp.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}